ANNUNZIATA, MARIA CARMELA
ANNUNZIATA, MARIA CARMELA
Dipartimento di Medicina clinica e Chirurgia
Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy
2022 Marasca, Claudio; Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Fabbrocini, Gabriella
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature
2020 Cacciapuoti, Sara; Luciano, Maria A; Megna, Matteo; Annunziata, Maria C; Napolitano, Maddalena; Patruno, Cataldo; Scala, Emanuele; Colicchio, Roberta; Pagliuca, Chiara; Salvatore, Paola; Fabbrocini, Gabriella
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
2023 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects
2022 Martora, Fabrizio; Fornaro, Luigi; Picone, Vincenzo; Marasca, Dario; Gargiulo, Maurizio; Annunziata, Maria Carmela; Fabbrocini, Gabriella; Marasca, Claudio
Maskne prevalence and risk factors during the COVID-19 pandemic
2022 Villani, A; Fabbrocini, G; Annunziata, M C; Potestio, L
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa
2020 Marasca, Claudio; Marasca, Dario; Megna, Matteo; Annunziata, MARIA CARMELA; Fabbrocini, Gabriella
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
2022 Marasca, C.; Annunziata, M. C.; Camela, E.; Di Guida, A.; Fornaro, L.; Megna, M.; Napolitano, M.; Patruno, C.; Potestio, L.; Fabbrocini, G.
Long-term results of teledermatology for acne patients during COVID-19 pandemic
2022 Villani, Alessia; Annunziata, Maria Carmela; Megna, Matteo; Scalvenzi, Massimiliano; Fabbrocini, Gabriella
Phosphorylation sites in protein kinases and phosphatases regulated by formyl peptide receptor 2 signaling
2020 Annunziata, M. C.; Parisi, M.; Esposito, G.; Fabbrocini, G.; Ammendola, R.; Cattaneo, F.
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast
2019 Fattore, D.; Annunziata, M. C.; Panariello, L.; Marasca, C.; Fabbrocini, G.
Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes"
2019 Marasca, Claudio; Masarà, Anna; Annunziata, Maria Carmela; Fattore, Davide; Fabbrocini, Gabriella
A novel treatment for retronychia: case series
2020 Vastarella, M.; Annunziata, M. C.; Panariello, L.; Ferrillo, M.; Fabbrocini, G.
Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case
2019 Marasca, C.; Fontanella, G.; Annunziata, M. C.; Marasca, D.; Fabbrocini, G.
Retrospective analysis of skin toxicity in patients under anti-EGFR tyrosine kinase inhibitors: Our experience in lung cancer
2019 Annunziata, M. C.; Ferrillo, M.; Cinelli, E.; Panariello, L.; Rocco, D.; Fabbrocini, G.
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study
2019 Marasca, Claudio; Annunziata, Maria Carmela; Villani, Alessia; Volpe, Salvatore; Marasca, Dario; Fabbrocini, Gabriella
Treatment outcomes of immune-related cutaneous adverse events
2019 Phillips, G. S.; Wu, J.; Hellmann, M. D.; Postow, M. A.; Rizvi, N. A.; Freites-Martinez, A.; Chan, D.; Dusza, S.; Motzer, R. J.; Rosenberg, J. E.; Callahan, M. K.; Chapman, P. B.; Geskin, L.; Lopez, A. T.; Reed, V. A.; Fabbrocini, G.; Annunziata, M. C.; Kukoyi, O.; Pabani, A.; Yang, C. -H.; Chung, W. -H.; Markova, A.; Lacouture, M. E.
Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer
2019 Annunziata, M. C.; De Stefano, A.; Fabbrocini, G.; Leo, S.; Marchetti, P.; Romano, M. C.; Romano, I.
Comment on ‘The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B12 levels in patients with acne’: may retinoids be useful to treat hyperhomocysteinemia found in patients affected by hidradenitis suppurativa?
2020 Marasca, C.; Donnarumma, M.; Annunziata, M. C.; Fabbrocini, G.
Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa
2020 Marasca, C.; Cinelli, E.; Annunziata, M. C.; Barrea, L.; Savastano, S.; Fabbrocini, G.
Quality of life in people living with patients suffering from hidradenitis suppurativa
2020 Marasca, C.; Napolitano, M.; Monfrecola, G.; Masara, A.; Annunziata, M. C.; Donnarumma, M.; Fabbrocini, G.
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Biologics for patients affected by Hidradenitis suppurativa in the COVID-19 era: data from a referral centre of Southern Italy | 1.1 Articolo in rivista | 2022 | Marasca, Claudio; Ruggiero, Angelo; Megna, Matteo; Annunziata, Maria Carmela; Fabbrocini, Gabriella | |
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature | 1.1 Articolo in rivista | 2020 | Cacciapuoti, Sara; Luciano, Maria A; Megna, Matteo; Annunziata, Maria C; Napolitano, Maddalena; Patruno, Cataldo; Scala, Emanuele; Colicchio, Roberta; Pagliuca, Chiara; Salvatore, Paola; Fabbrocini, Gabriella | |
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella | |
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Fornaro, Luigi; Picone, Vincenzo; Marasca, Dario; Gargiulo, Maurizio; Annunziata, Maria Carmela; Fabbrocini, Gabriella; Marasca, Claudio | |
Maskne prevalence and risk factors during the COVID-19 pandemic | 1.1 Articolo in rivista | 2022 | Villani, A; Fabbrocini, G; Annunziata, M C; Potestio, L | |
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa | 1.1 Articolo in rivista | 2020 | Marasca, Claudio; Marasca, Dario; Megna, Matteo; Annunziata, MARIA CARMELA; Fabbrocini, Gabriella | |
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications | 1.1 Articolo in rivista | 2022 | Marasca, C.; Annunziata, M. C.; Camela, E.; Di Guida, A.; Fornaro, L.; Megna, M.; Napolitano, M.; Patruno, C.; Potestio, L.; Fabbrocini, G. | |
Long-term results of teledermatology for acne patients during COVID-19 pandemic | 1.1 Articolo in rivista | 2022 | Villani, Alessia; Annunziata, Maria Carmela; Megna, Matteo; Scalvenzi, Massimiliano; Fabbrocini, Gabriella | |
Phosphorylation sites in protein kinases and phosphatases regulated by formyl peptide receptor 2 signaling | 1.1 Articolo in rivista | 2020 | Annunziata, M. C.; Parisi, M.; Esposito, G.; Fabbrocini, G.; Ammendola, R.; Cattaneo, F. | |
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast | 1.1 Articolo in rivista | 2019 | Fattore, D.; Annunziata, M. C.; Panariello, L.; Marasca, C.; Fabbrocini, G. | |
Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes" | 1.1 Articolo in rivista | 2019 | Marasca, Claudio; Masarà, Anna; Annunziata, Maria Carmela; Fattore, Davide; Fabbrocini, Gabriella | |
A novel treatment for retronychia: case series | 1.1 Articolo in rivista | 2020 | Vastarella, M.; Annunziata, M. C.; Panariello, L.; Ferrillo, M.; Fabbrocini, G. | |
Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case | 1.1 Articolo in rivista | 2019 | Marasca, C.; Fontanella, G.; Annunziata, M. C.; Marasca, D.; Fabbrocini, G. | |
Retrospective analysis of skin toxicity in patients under anti-EGFR tyrosine kinase inhibitors: Our experience in lung cancer | 1.1 Articolo in rivista | 2019 | Annunziata, M. C.; Ferrillo, M.; Cinelli, E.; Panariello, L.; Rocco, D.; Fabbrocini, G. | |
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study | 1.1 Articolo in rivista | 2019 | Marasca, Claudio; Annunziata, Maria Carmela; Villani, Alessia; Volpe, Salvatore; Marasca, Dario; Fabbrocini, Gabriella | |
Treatment outcomes of immune-related cutaneous adverse events | 1.1 Articolo in rivista | 2019 | Phillips, G. S.; Wu, J.; Hellmann, M. D.; Postow, M. A.; Rizvi, N. A.; Freites-Martinez, A.; Chan, D.; Dusza, S.; Motzer, R. J.; Rosenberg, J. E.; Callahan, M. K.; Chapman, P. B.; Geskin, L.; Lopez, A. T.; Reed, V. A.; Fabbrocini, G.; Annunziata, M. C.; Kukoyi, O.; Pabani, A.; Yang, C. -H.; Chung, W. -H.; Markova, A.; Lacouture, M. E. | |
Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer | 1.1 Articolo in rivista | 2019 | Annunziata, M. C.; De Stefano, A.; Fabbrocini, G.; Leo, S.; Marchetti, P.; Romano, M. C.; Romano, I. | |
Comment on ‘The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B12 levels in patients with acne’: may retinoids be useful to treat hyperhomocysteinemia found in patients affected by hidradenitis suppurativa? | 1.1 Articolo in rivista | 2020 | Marasca, C.; Donnarumma, M.; Annunziata, M. C.; Fabbrocini, G. | |
Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa | 1.1 Articolo in rivista | 2020 | Marasca, C.; Cinelli, E.; Annunziata, M. C.; Barrea, L.; Savastano, S.; Fabbrocini, G. | |
Quality of life in people living with patients suffering from hidradenitis suppurativa | 1.1 Articolo in rivista | 2020 | Marasca, C.; Napolitano, M.; Monfrecola, G.; Masara, A.; Annunziata, M. C.; Donnarumma, M.; Fabbrocini, G. |